This company has been marked as potentially delisted and may not be actively trading. UNITY Biotechnology (UBX) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for UNITY Biotechnology (NASDAQ:UBX)CurrentInstitutional OwnershipPercentage29.49%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$371.53KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$665.53K Get UBX Insider Trade Alerts Want to know when executives and insiders are buying or selling UNITY Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data UBX Institutional Buying and Selling by Quarter UNITY Biotechnology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 Alyeska Investment Group L.P.292,091$304K0.0%-66.0%1.697% 5/5/2025 Financial Harvest LLC205,270$213K0.1%N/A1.193% 4/11/2025 SeaCrest Wealth Management LLC27,800$29K0.0%N/A0.165% 2/17/2025 Bridgeway Capital Management LLC50,000$49K0.0%+100.0%0.297% 2/17/2025 Alyeska Investment Group L.P.859,083$839K0.0%-6.6%5.098% 2/13/2025 Renaissance Technologies LLC76,911$75K0.0%-17.9%0.456% 11/16/2024 Geode Capital Management LLC163,242$240K0.0%+9.5%0.969% 10/23/2024 Ballentine Partners LLC57,046$84K0.0%N/A0.340% 8/9/2024 Renaissance Technologies LLC64,582$87K0.0%-39.6%0.385% 2/13/2024 Armistice Capital LLC688,000$1.33M0.0%N/A4.100% Get the Latest News and Ratings for UBX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for UNITY Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 8/9/2023Mayo Clinic124,081$316K0.3%-21.1%0.864% 7/27/2023 Virtu Financial LLC17,949$46K0.0%N/A0.125% 5/16/2023 Founders Fund V Management LLC49,172$80K6.2%-90.0%0.342% 5/1/2023 Arete Wealth Advisors LLC10,392$142.30B0.0%N/A0.072% 2/14/2023 683 Capital Management LLC240,000$658K0.1%-91.5%1.691% 2/9/2023Mayo Clinic157,198$431K0.2%N/A1.108% 2/8/2023 Prime Capital Investment Advisors LLC11,420$31K0.0%N/A0.080% 2/7/2023 Commonwealth Equity Services LLC16,013$43K0.0%-62.8%0.113% 2/6/2023 Arete Wealth Advisors LLC10,392$140.58B0.0%N/A0.073% 2/2/2023 Bailard Inc.17,700$48K0.0%-65.3%0.125% 1/26/2023Mayo Clinic157,198$431K2.2%N/A1.108% 11/16/2022 Maven Securities LTD100,000$40K0.0%N/A0.705% 11/15/2022 Parkman Healthcare Partners LLC404,092$160K0.0%N/A2.847% 11/15/2022 Laurion Capital Management LP700,000$277K0.0%N/A4.933% 11/15/2022Empery Asset Management LP4,411,645$1.74M10.4%N/A31.090% 11/14/2022 683 Capital Management LLC2,822,449$1.12M0.1%N/A19.888% 11/14/2022 Altium Capital Management LP4,270,000$1.69M0.6%N/A30.087% 11/14/2022 UBS Oconnor LLC606,500$240K0.0%N/A4.274% 11/14/2022 Maven Securities LTD100,000$40K0.0%N/A0.705% 11/10/2022 ARCH Venture Management LLC10,048,181$3.97M0.5%N/A75.059% 11/10/2022 Connor Clark & Lunn Investment Management Ltd.162,043$64K0.0%N/A1.210% 11/10/2022 ExodusPoint Capital Management LP509,892$201K0.0%N/A3.808% 5/12/2022 Connor Clark & Lunn Investment Management Ltd.33,917$38K0.0%-64.0%0.049% 5/11/2022 GSA Capital Partners LLP724,202$811K0.1%+4.0%1.047% 2/14/2022 GSA Capital Partners LLP696,115$1.02M0.1%+48.9%1.206% 2/10/2022 Acadian Asset Management LLC278,796$405K0.0%N/A0.483% 2/10/2022 Connor Clark & Lunn Investment Management Ltd.94,282$138K0.0%N/A0.163% 11/16/2021 Two Sigma Advisers LP155,200$466K0.0%+178.6%0.282% 11/16/2021 Two Sigma Investments LP264,216$793K0.0%+64.9%0.479% 11/15/2021 Marshall Wace LLP124,117$373K0.0%+210.7%0.225% 11/15/2021 Franklin Resources Inc.92,900$279K0.0%N/A0.169% 11/15/2021 GSA Capital Partners LLP467,371$1.40M0.1%+127.0%0.848% 11/12/2021 Renaissance Technologies LLC640,700$1.92M0.0%+25.0%1.163% 11/12/2021 Geode Capital Management LLC318,673$956K0.0%+4.1%0.578% 11/9/2021BlackRock Inc.900,630$2.70M0.0%+2.0%1.635% 11/8/2021 Russell Investments Group Ltd.34,710$103K0.0%-66.8%0.063% 11/4/2021 Deutsche Bank AG168,158$504K0.0%-34.8%0.305% 10/27/2021 Moloney Securities Asset Management LLC21,000$63K0.0%N/A0.038% 10/19/2021 Baillie Gifford & Co.589,111$1.77M0.0%-74.4%1.069% 9/3/2021Parametric Portfolio Associates LLC31,399$146K0.0%-30.6%0.057% 8/25/2021 Marshall Wace LLP39,942$186K0.0%N/A0.072% 8/25/2021Marshall Wace North America L.P.14,397$67K0.0%N/A0.026% 8/17/2021 Walleye Capital LLC45,845$213K0.0%N/A0.083% 8/17/2021 Walleye Trading LLC16,378$76K0.0%N/A0.030% 8/17/2021 Millennium Management LLC606,041$2.81M0.0%N/A1.100% 8/17/2021 Boothbay Fund Management LLC10,002$46K0.0%N/A0.018% 8/16/2021 LMR Partners LLP19,158$89K0.0%N/A0.035% 8/16/2021 PDT Partners LLC74,178$344K0.0%+5.6%0.135% 8/16/2021 Occudo Quantitative Strategies LP64,789$301K0.0%N/A0.118% 8/16/2021 Morgan Stanley914,566$4.24M0.0%+445.2%1.660% 8/16/2021 Schonfeld Strategic Advisors LLC17,900$83K0.0%N/A0.032% 8/16/2021 Charles Schwab Investment Management Inc.143,577$667K0.0%-36.6%0.261% 8/16/2021 State Street Corp102,740$477K0.0%-82.8%0.186% 8/16/2021Tibra Equities Europe Ltd80,700$374K0.1%N/A0.146% 8/16/2021 Marshall Wace LLP39,942$186K0.0%N/A0.072% 8/13/2021 Renaissance Technologies LLC512,600$2.38M0.0%N/A0.930% 8/13/2021 Northern Trust Corp61,022$284K0.0%-83.4%0.111% 8/13/2021 Jump Financial LLC33,700$156K0.0%N/A0.061% 8/13/2021 Qube Research & Technologies Ltd45,133$209K0.0%N/A0.082% 8/13/2021 AXA S.A.21,000$97K0.0%-82.2%0.038% 8/13/2021 Geode Capital Management LLC306,245$1.42M0.0%-44.8%0.558% 8/13/2021 Vanguard Group Inc.1,417,933$6.58M0.0%-10.4%2.585% 8/13/2021 FMR LLC4,032,319$18.71M0.0%-2.0%7.351% 8/12/2021 JPMorgan Chase & Co.163,324$758K0.0%+32.7%0.298% 8/12/2021Ergoteles LLC162,100$752K0.0%N/A0.296% 8/11/2021 Commonwealth Equity Services LLC12,197$56K0.0%N/A0.022% 8/11/2021 Bank of New York Mellon Corp36,393$169K0.0%-65.5%0.066% 8/11/2021BlackRock Inc.882,571$4.09M0.0%-69.0%1.609% 8/11/2021 Deutsche Bank AG257,966$1.20M0.0%+857.7%0.470% 8/10/2021 Citigroup Inc.29,607$137K0.0%+12.1%0.054% 8/4/2021 Russell Investments Group Ltd.104,406$481K0.0%-43.6%0.190% 8/2/2021 Advisor Group Holdings Inc.25,310$116K0.0%-32.0%0.046% 5/18/2021 Morgan Stanley167,741$1.01M0.0%-57.7%0.306% (Data available from 1/1/2016 forward) UBX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of UBX shares? During the previous two years, the following institutional investors and hedge funds held shares of UNITY Biotechnology shares: Armistice Capital LLC ($1.33M), Alyeska Investment Group L.P. ($304K), Geode Capital Management LLC ($240K), Financial Harvest LLC ($213K), Ballentine Partners LLC ($84K), Renaissance Technologies LLC ($75K), and Bridgeway Capital Management LLC ($49K).Learn more on UNITY Biotechnology's institutional investors. What percentage of UNITY Biotechnology's stock is owned by institutional investors? 29.49% of UNITY Biotechnology's stock is owned by institutional investors. Learn more on UBX's institutional investor holdings. Which institutional investors have been buying UNITY Biotechnology's stock? The following institutional investors have purchased UNITY Biotechnology's stock in the last 24 months: Armistice Capital LLC ($688K), Financial Harvest LLC ($205.27K), Ballentine Partners LLC ($57.05K), SeaCrest Wealth Management LLC ($27.80K), Bridgeway Capital Management LLC ($25K), and Geode Capital Management LLC ($14.20K). How much institutional buying is happening at UNITY Biotechnology? Institutional investors have bought a total of 329,315 shares in the last 24 months. This purchase volume represents approximately $371.53K in transactions. Which of UNITY Biotechnology's major shareholders have been selling company stock? The following institutional investors have sold UNITY Biotechnology stock in the last 24 months: Alyeska Investment Group L.P. ($627.92K), and Renaissance Technologies LLC ($16.76K). How much institutional selling is happening at UNITY Biotechnology? Institutional investors have sold a total of 644,681 shares in the last 24 months. This volume of shares sold represents approximately $665.53K in transactions. Related Companies HCW Biologics Institutional Ownership Bullfrog AI Institutional Ownership IM Cannabis Institutional Ownership Marker Therapeutics Institutional Ownership Leap Therapeutics Institutional Ownership Moleculin Biotech Institutional Ownership GeoVax Labs Institutional Ownership Flora Growth Institutional Ownership Gelteq Institutional Ownership BioCardia Institutional Ownership This page (NASDAQ:UBX) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding UNITY Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share UNITY Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
